Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Association_for_Molecular_Pathology_v._Myriad_Genetics> ?p ?o. }
Showing items 1 to 41 of
41
with 100 items per page.
- Association_for_Molecular_Pathology_v._Myriad_Genetics abstract "Association for Molecular Pathology v. Myriad Genetics, 569 U.S. 12-398 (2013) was a case challenging the validity of gene patents in the United States, specifically challenging certain claims in issued patents owned or controlled by Myriad Genetics that cover isolated DNA sequences, methods to diagnose propensity to cancer by looking for mutated DNA sequences, and methods to identify drugs using isolated DNA sequences. Prior to the case, the U.S. Patent Office accepted patents on isolated DNA sequences as a composition of matter. Diagnostic claims were already under question through the In re Bilski and Mayo v. Prometheus cases. Drug screening claims were not seriously questioned prior to this case.The case was originally heard in Southern District Court of New York, which ruled that all the challenged claims were not patent eligible. Myriad then appealed to the Federal Circuit Appeals Court. The Circuit court overturned the previous decision in part, ruling that isolated DNA which does not exist alone in nature can be patented and that the drug screening claims were valid, and confirmed in part, finding the diagnostic claims unpatentable. The plaintiffs appealed to the Supreme Court, which granted certiorari and remanded the case to the Federal Circuit. The Federal Circuit did not change its opinion, so on September 25, 2012, the American Civil Liberties Union and the Public Patent Foundation filed a petition for certiorari with the Supreme Court with respect to the second Federal Circuit Decision. On November 30, 2012, the Supreme Court agreed to hear the plaintiffs' appeal of the Federal Circuit's ruling. On June 13, 2013, in a unanimous decision, the Supreme Court invalidated Myriad's claims to isolated genes. The Court held that merely isolating genes that are found in nature does not make them patentable.Proponents of the validity of these patents argued that they encourage investment in biotechnology and promote innovation in genetic research by not keeping technology shrouded in secrecy. Opponents argued that these patents stifle innovation by preventing others from conducting cancer research, limit options for cancer patients in seeking genetic testing, and are not valid because they claim genetic information that is not inventive, but is rather produced by nature.".
- Association_for_Molecular_Pathology_v._Myriad_Genetics wikiPageExternalLink 534.
- Association_for_Molecular_Pathology_v._Myriad_Genetics wikiPageExternalLink 101.
- Association_for_Molecular_Pathology_v._Myriad_Genetics wikiPageExternalLink 12-398_1b7d.pdf.
- Association_for_Molecular_Pathology_v._Myriad_Genetics wikiPageID "29052582".
- Association_for_Molecular_Pathology_v._Myriad_Genetics wikiPageRevisionID "599178184".
- Association_for_Molecular_Pathology_v._Myriad_Genetics arguedate "--04-15".
- Association_for_Molecular_Pathology_v._Myriad_Genetics argueyear "2013".
- Association_for_Molecular_Pathology_v._Myriad_Genetics concurrence "Scalia".
- Association_for_Molecular_Pathology_v._Myriad_Genetics decidedate "--06-13".
- Association_for_Molecular_Pathology_v._Myriad_Genetics decideyear "2013".
- Association_for_Molecular_Pathology_v._Myriad_Genetics docket "12".
- Association_for_Molecular_Pathology_v._Myriad_Genetics fullname "Association for Molecular Pathology, et al. v. Myriad Genetics, Inc., et al.".
- Association_for_Molecular_Pathology_v._Myriad_Genetics hasPhotoCollection Association_for_Molecular_Pathology_v._Myriad_Genetics.
- Association_for_Molecular_Pathology_v._Myriad_Genetics holding "Naturally occurring DNA sequences, even when isolated from the body, cannot be patented, but artificially created DNA is patent eligible because it is not naturally occurring.".
- Association_for_Molecular_Pathology_v._Myriad_Genetics joinmajority "Roberts, Kennedy, Ginsburg, Breyer, Alito, Sotomayor, Kagan, Scalia".
- Association_for_Molecular_Pathology_v._Myriad_Genetics lawsapplied "35".
- Association_for_Molecular_Pathology_v._Myriad_Genetics litigants "Association for Molecular Pathology v. Myriad Genetics, Inc.".
- Association_for_Molecular_Pathology_v._Myriad_Genetics majority "Thomas".
- Association_for_Molecular_Pathology_v._Myriad_Genetics prior "172800.0".
- Association_for_Molecular_Pathology_v._Myriad_Genetics scotus "2010".
- Association_for_Molecular_Pathology_v._Myriad_Genetics uspage "___".
- Association_for_Molecular_Pathology_v._Myriad_Genetics usvol "569".
- Association_for_Molecular_Pathology_v._Myriad_Genetics subject Category:2013_in_United_States_case_law.
- Association_for_Molecular_Pathology_v._Myriad_Genetics subject Category:Biological_patent_law.
- Association_for_Molecular_Pathology_v._Myriad_Genetics subject Category:United_States_Court_of_Appeals_for_the_Federal_Circuit_cases.
- Association_for_Molecular_Pathology_v._Myriad_Genetics subject Category:United_States_Supreme_Court_cases.
- Association_for_Molecular_Pathology_v._Myriad_Genetics subject Category:United_States_patent_case_law.
- Association_for_Molecular_Pathology_v._Myriad_Genetics type Case.
- Association_for_Molecular_Pathology_v._Myriad_Genetics type LegalCase.
- Association_for_Molecular_Pathology_v._Myriad_Genetics type SupremeCourtOfTheUnitedStatesCase.
- Association_for_Molecular_Pathology_v._Myriad_Genetics type UnitOfWork.
- Association_for_Molecular_Pathology_v._Myriad_Genetics type Situation.
- Association_for_Molecular_Pathology_v._Myriad_Genetics comment "Association for Molecular Pathology v. Myriad Genetics, 569 U.S. 12-398 (2013) was a case challenging the validity of gene patents in the United States, specifically challenging certain claims in issued patents owned or controlled by Myriad Genetics that cover isolated DNA sequences, methods to diagnose propensity to cancer by looking for mutated DNA sequences, and methods to identify drugs using isolated DNA sequences. Prior to the case, the U.S.".
- Association_for_Molecular_Pathology_v._Myriad_Genetics label "Association for Molecular Pathology v. Myriad Genetics".
- Association_for_Molecular_Pathology_v._Myriad_Genetics sameAs m.0dgrstf.
- Association_for_Molecular_Pathology_v._Myriad_Genetics sameAs Q4809485.
- Association_for_Molecular_Pathology_v._Myriad_Genetics sameAs Q4809485.
- Association_for_Molecular_Pathology_v._Myriad_Genetics wasDerivedFrom Association_for_Molecular_Pathology_v._Myriad_Genetics?oldid=599178184.
- Association_for_Molecular_Pathology_v._Myriad_Genetics isPrimaryTopicOf Association_for_Molecular_Pathology_v._Myriad_Genetics.
- Association_for_Molecular_Pathology_v._Myriad_Genetics name "Association for Molecular Pathology, et al. v. Myriad Genetics, Inc., et al.".